Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04645524 · ClinicalTrials.gov registry record · Phase 2
Crossover Trial of AD182 and AD504 in Obstructive Sleep Apnea
A Phase 2 study, sponsored by Apnimed.
- Completed
- Registry status
- Phase 2
- Development phase
- 15
- Enrollment target
NCT04645524 is a Phase 2 study that has completed, run by Apnimed. The registered enrollment target is 15 participants.
The verdict
NCT04645524, a Phase 2 study, has completed, sponsored by Apnimed.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 15 participants
- Enrollment target
Study Summary
This is a randomized, 3-period, placebo-controlled, crossover study to examine the efficacy and safety of AD182 and AD504 versus placebo in patients with obstructive sleep apnea.
Interventions
- DRUG Placebo
- DIAGNOSTIC_TEST Polysomnography
- DRUG AD504
- DRUG AD182
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2020-12-01 |
| Est. Completion | 2021-09-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04645524
The ClinicalTrials.gov registry entry for NCT04645524 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Apnimed, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT04645524 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04645524 about?
NCT04645524 is a clinical study titled "Crossover Trial of AD182 and AD504 in Obstructive Sleep Apnea". This is a randomized, 3-period, placebo-controlled, crossover study to examine the efficacy and safety of AD182 and AD504 versus placebo in patients with obstructive sleep apnea.
What is the current status of trial NCT04645524?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 15 participants. The study started on 2020-12-01. Estimated completion is 2021-09-01.
What interventions are being tested in trial NCT04645524?
The interventions under investigation include: Placebo (DRUG), Polysomnography (DIAGNOSTIC_TEST), AD504 (DRUG), AD182 (DRUG).
Who is sponsoring clinical trial NCT04645524?
This trial is sponsored by Apnimed, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.